The FOx Biosystems technology has been featured in a new publication in the Journal of Extracellular Vesicles.
Scientists at KU Leuven have shown that it can be used as a fast and accurate method of detecting extracellular vesicles at physiologically relevant concentrations.
This is just our first step in revolutionizing the use of these EVs for the diagnosis, prognosis and therapy of many serious diseases, including cardiovascular disease and cancer.
Read the full paper here.